# Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population

> **NCT05070039** · NA · COMPLETED · sponsor: **Sohag University** · enrollment: 40 (actual)

## Conditions studied

- Urothelial Carcinoma

## Interventions

- **GENETIC:** Expression of Cortactin anti body

## Key facts

- **NCT ID:** NCT05070039
- **Lead sponsor:** Sohag University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-01
- **Primary completion:** 2021-12-30
- **Final completion:** 2022-01-01
- **Target enrollment:** 40 (ACTUAL)
- **Last updated:** 2022-07-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05070039

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05070039, "Value of Cortactin Expression in Invasive and Non-invasive Urinary Bladder Urothelial Carcinoma in Egyptian Population". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT05070039. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*